# Replimune Group, Inc.: filings

REPL · Nasdaq · CIK 1737953 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/repl.md) · [Financials](/companies/repl/financials.md) · [Filings](/companies/repl/filings.md) · [Insiders](/companies/repl/insiders.md)

## Reports and events: 169 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 281, 8-K 111, SC 13G/A 34, 3 32, 10-Q 26, S-8 13, 424B5 12, SC 13G 12, UPLOAD 12, 144 11, CORRESP 11, SCHEDULE 13G/A 11, 10-K 8, DEF 14A 8, EFFECT 7, DEFA14A 6, S-3 6, SC 13D/A 5, ARS 4, SCHEDULE 13G 4, 8-K/A 3, S-1/A 3, CT ORDER 2, DRS/A 2, DRSLTR 2, FWP 2, PRE 14A 2, S-3/A 2, S-3ASR 2, 10-K/A 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, POS AM 1, POSASR 1, PRER14A 1, S-1 1, SC 13D 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 07:25 ET | [10-Q](/filings/0001628280-26-067722.md) | Quarterly report, period 2026-09-30 | 0001628280-26-067722 |
| 2026-10-28 | 07:05 ET | [8-K](/filings/0001104659-26-119354.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-119354 |
| 2026-09-16 | 16:05 ET | [8-K](/filings/0001104659-26-108243.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-108243 |
| 2026-08-14 | 16:07 ET | [10-Q](/filings/0001628280-26-057099.md) | Quarterly report, period 2026-06-30 | 0001628280-26-057099 |
| 2026-08-14 | 08:10 ET | [8-K](/filings/0001104659-26-096483.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-096483 |
| 2026-08-11 | 17:50 ET | [SCHEDULE 13D/A](/filings/0001104659-26-094196.md) | Ownership report, active investor, amended | 0001104659-26-094196 |
| 2026-08-11 | 18:37 ET | [8-K/A](/filings/0001104659-26-093512.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-093512 |
| 2026-08-10 | 07:50 ET | [8-K](/filings/0001104659-26-093042.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-093042 |
| 2026-08-07 | 21:27 ET | [8-K](/filings/0001104659-26-092246.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-092246 |
| 2026-07-31 | 20:02 ET | [8-K](/filings/0001104659-26-088857.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088857 |
| 2026-07-30 | 08:06 ET | [8-K](/filings/0001104659-26-088481.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-088481 |
| 2026-07-29 | 18:14 ET | [DEF 14A](/filings/0001104659-26-087650.md) | Proxy statement, period 2026-09-15 | 0001104659-26-087650 |
| 2026-06-29 | 08:12 ET | [10-K](/filings/0001628280-26-045886.md) | Annual report, period 2026-03-31 | 0001628280-26-045886 |
| 2026-06-29 | 08:11 ET | [8-K](/filings/0001104659-26-078511.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-078511 |
| 2026-06-26 | 08:14 ET | [8-K](/filings/0001104659-26-078009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-078009 |
| 2026-05-29 | 09:56 ET | [8-K](/filings/0001104659-26-068002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-068002 |
| 2026-04-13 | 17:59 ET | [8-K](/filings/0001104659-26-042141.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-042141 |
| 2026-02-03 | 08:12 ET | [10-Q](/filings/0001628280-26-004805.md) | Quarterly report, period 2025-12-31 | 0001628280-26-004805 |
| 2026-02-03 | 08:05 ET | [8-K](/filings/0001104659-26-009510.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-009510 |
| 2026-01-12 | 08:00 ET | [8-K](/filings/0001104659-26-002721.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002721 |
| 2025-11-06 | 08:20 ET | [8-K](/filings/0001104659-25-107438.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107438 |
| 2025-11-06 | 08:07 ET | [10-Q](/filings/0001628280-25-049884.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049884 |
| 2025-10-20 | 07:20 ET | [8-K](/filings/0001104659-25-100605.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100605 |
| 2025-09-18 | 09:20 ET | [8-K](/filings/0001104659-25-091066.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-091066 |
| 2025-09-04 | 16:05 ET | [8-K](/filings/0001104659-25-087464.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-087464 |
| 2025-08-07 | 08:07 ET | [10-Q](/filings/0001737953-25-000013.md) | Quarterly report, period 2025-06-30 | 0001737953-25-000013 |
| 2025-08-07 | 08:05 ET | [8-K](/filings/0001104659-25-074989.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074989 |
| 2025-07-25 | 16:16 ET | [DEF 14A](/filings/0001104659-25-070833.md) | Proxy statement, period 2025-09-03 | 0001104659-25-070833 |
| 2025-07-22 | 08:18 ET | [8-K](/filings/0001104659-25-069489.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-069489 |
| 2025-06-24 | 16:30 ET | [8-K](/filings/0001104659-25-062122.md) | 7.01 Regulation FD disclosure | 0001104659-25-062122 |
| 2025-05-22 | 17:12 ET | [10-K](/filings/0001737953-25-000009.md) | Annual report, period 2025-03-31 | 0001737953-25-000009 |
| 2025-05-22 | 08:05 ET | [8-K](/filings/0001104659-25-051847.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-051847 |
| 2025-03-07 | 17:07 ET | [SCHEDULE 13D](/filings/0001104659-25-021795.md) | Ownership report, active investor | 0001104659-25-021795 |
| 2025-03-07 | 16:30 ET | [8-K](/filings/0001104659-25-021756.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-021756 |
| 2025-02-12 | 08:07 ET | [10-Q](/filings/0001737953-25-000004.md) | Quarterly report, period 2024-12-31 | 0001737953-25-000004 |
| 2025-02-12 | 08:06 ET | [8-K](/filings/0001104659-25-011851.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-011851 |
| 2025-01-22 | 17:00 ET | [8-K](/filings/0001104659-25-005291.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-005291 |
| 2024-12-04 | 08:30 ET | [8-K/A](/filings/0001104659-24-125370.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-125370 |
| 2024-11-27 | 08:30 ET | [8-K](/filings/0001104659-24-123451.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-123451 |
| 2024-11-26 | 08:30 ET | [8-K](/filings/0001104659-24-122860.md) | 8.01 Other events | 0001104659-24-122860 |
| 2024-11-21 | 17:26 ET | [8-K](/filings/0001104659-24-121616.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-121616 |
| 2024-11-12 | 08:16 ET | [10-Q](/filings/0001737953-24-000015.md) | Quarterly report, period 2024-09-30 | 0001737953-24-000015 |
| 2024-11-12 | 08:05 ET | [8-K](/filings/0001104659-24-116413.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116413 |
| 2024-09-05 | 16:05 ET | [8-K](/filings/0001104659-24-097365.md) | 5.07 Shareholder vote results | 0001104659-24-097365 |
| 2024-08-08 | 08:06 ET | [10-Q](/filings/0001737953-24-000013.md) | Quarterly report, period 2024-06-30 | 0001737953-24-000013 |
| 2024-08-08 | 08:04 ET | [8-K](/filings/0001104659-24-087035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087035 |
| 2024-07-19 | 16:15 ET | [DEF 14A](/filings/0001104659-24-081167.md) | Proxy statement, period 2024-09-04 | 0001104659-24-081167 |
| 2024-06-13 | 08:36 ET | [8-K](/filings/0001104659-24-071078.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-071078 |
| 2024-06-06 | 09:15 ET | [8-K](/filings/0001104659-24-068948.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068948 |
| 2024-06-03 | 09:27 ET | [8-K](/filings/0001104659-24-067556.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067556 |

Page 1 of 4. [Older](/companies/repl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:44 ET. No prices; not investment advice.